Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by flymaron Oct 28, 2012 10:07am
265 Views
Post# 20532169

RE: RE: RE: RE: Further updates on current drillin

RE: RE: RE: RE: Further updates on current drillin

I noted the same re news as you Kewl2.  I do my own investing sans broker and the news from Brigus is never published on my self directed investment site or the Investor Point where I check who is buying selling etc.  On the other hand insiders are not selling shares.  The share price seems to be dictated by the American exchange.

Although they are reporting the good news they are keeping it very low key.  All resouce shares are in the dumster so maybe they are waiting for price of gold to improve and don't want hostile takeovers.  None of us knows what decisions are being made.  Brigus is my biggest position and I have 2 yr. timeframe for it to at least double from here.

I have done well with Sandstorm thanks to you but I did sell all my shares perhaps a little too soon when the company consolidated although I still have a lot of the warrants.  Sandstorm is constantly in the news and Brigus is trying to get out of the stream somewhat  so they will piggyback on Sand's success.  I discovered Brigus through SSL and I'm a nobody investment wise.

GLTA  flymar

Bullboard Posts